Epidemiology of Melanoma

Seminars in Cutaneous Medicine and Surgery

Volumn 29, Issue 4, 2010, Pages 204-209

  Rigel, Darrell S ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; IMMUNE DEFICIENCY; LIGHT EXPOSURE; MELANOMA; NEVUS; SKIN CANCER; SOCIAL STATUS; SUNLIGHT; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

DYSPLASTIC NEVUS SYNDROME; HUMANS; IMMUNOSUPPRESSION; INCIDENCE; MELANOMA; PEDIGREE; PUVA THERAPY; RISK FACTORS; SKIN NEOPLASMS; SOCIAL CLASS; SUNBURN; SUNLIGHT; ULTRAVIOLET RAYS; UNITED STATES;

EID: 79251509240     PISSN: 10855629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sder.2010.10.005     Document Type: Article

References (63)

1. Linos E., Swetter S.M., Cockburn M.G., et al. Increasing burden of melanoma in the United States. J Invest Dermatol 2009, 129:1666-1674.
2. Jemal A., Siegel R., Ward E., et al. Cancer statistics. CA Cancer J Clin 2009, 59:225-249.
3. Rigel D.S., Russak J., Friedman R. The evolution of melanoma diagnosis: 25 years beyond the ABCDs. CA Cancer J Clin 2010, 60:301-316.
4. Kopf A.W., Rigel D.S., Friedman R.J. The rising incidence and mortality rate of malignant melanoma. J Dermatol Surg Oncol 1982, 8:760-761.
5. Overview of Cancer Prevalance Statistics National Cancer Institute, Accessed September 1, 2010. http://srab.cancer.gov/prevalence/.
6. Jemal A., Siegel R., Xu J., et al. Cancer statistics. CA Cancer J Clin 2010, 60:277-300.
7. Tsao H., Rogers G.S., Sober A.J. An estimate of the annual direct cost of treating cutaneous melanoma. J Am Acad Dermatol 1998, 38:669-680.
8. Rigel D.S., Carruci J. Malignant melanoma: prevention, early detection, and treatment in the 21st century. CA Cancer J Clin 2000, 50:215-236.
9. Mikkilineni R., Weinstock M.A. Epidemiology. Atlas of Clinical Oncology: Skin Cancer 2001, 1-15. BC Decker, London. A.J. Sober, F.G. Haluska (Eds.).
10. PubMed Accessed September 1, 2010. http://www.ncbi.nlm.nih.gov/pubmed.
11. SEER: SEER Stat Fact Sheets. Melanoma of the Skin Accessed September 1, 2010. http://seer.cancer.gov/statfacts/html/melan.html%23incidence-mortality.
12. SEER: An interactive tool for access to SEER cancer statistics. Surveillance Research Program, National Cancer Institute Accessed September 1, 2010. http://seer.cancer.gov/faststats.
13. Eide M.J., Weinstock M.A. Epidemiology of skin cancer. Cancer of the Skin 2011, Elsevier, Philadelphia, PA. D.S. Rigel (Ed.).
14. Pollitt R.A., Clarke C.A., Swetter S.M., et al. The expanding melanoma burden in California Hispanics: importance of socioeconomic distribution, histologic subtype, and anatomic location. Cancer 2010 Aug 24, (Epub ahead of print).
15. Fast Stats National Cancer Institute, Accessed September 1, 2010. http://seer.cancer.gov/faststats/selections.php?%23Output.
16. SEER: Table 1. Median age of cancer patients at death, 2002-2007 by primary cancer site, race and sex Accessed September 1, 2010. http://seer.cancer.gov/csr/1975_2007/results_single/sect_01_table.13_2pgs.pdf.
17. Weinstock M.A. Death from skin cancer among the elderly: epidemiologic patterns. Arch Dermatol 1997, 133:1207-1209.
18. American Cancer Society. http://www.cancer.org.
19. Ries L.A.G., Eisner M.P., Kosary C.L., et al. SEER Cancer Statistics Review, 1973-99 2002, National Cancer Institute, Bethesda.
20. Marrot L., Meunier J.R. Skin DNA photodamage and its biological consequences. J Am Acad Dermatol 2008, 58(5 suppl 2):S139-S148.
21. Ouhtit A., Nakazawa H., Armstrong B.K., et al. UV radiation specific p53 mutation frequency in normal skin as a predictor of risk of basal cell carcinoma. J Natl Cancer Inst 1998, 90:523-531.
22. Setlow R.B., Grist E., Thompson K., et al. Wavelengths effective in induction of malignant melanoma. Proc Natl Acad Sci U S A 1993, 90:6666-6670.
23. Ley R.D. Dose response for ultraviolet radiation A-induced focal melanocytic hyperplasia and nonmelanoma skin tumors in Monodelphis domestica. Photochem Photobiol 2001, 73:20-23.
24. Markovic S.N., Erickson L.A., Rao R.D., et al. Malignant melanoma in the 21st century. part 1: Epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc 2007, 82:364-380.
25. Armstrong B.K., Kricker A. Epidemiology of skin cancer. Photochem Photobiol 2001, 63:8-18.
26. Moan J., Dahlback A., Setlow A.B. Epidemiological support for an hypothesis for melanoma induction indicating a role for UVA radiation. Photochem Photobiol 1999, 70:243-247.
27. Rigel D.S., Rigel E.G., Rigel A.C. Effects of altitude and latitude on ambient UVB radiation. J Am Acad Dermatol 1999, 40:114-116.
28. Fears T.R., Bird C.C., Guerry D., et al. Average midrange ultraviolet radiation flux and time outdoors predict melanoma risk. Cancer Res 2002, 62:3992-3996.
29. Boniol M., De Vries E., Coebergh J.W., et al. Seasonal variation in the occurrence of cutaneous melanoma in Europe: influence of latitude. An analysis using the Eurocare group of registries. Eur J Cancer 2005, 41:126-132.
30. Bulliard J.L. Site-specific risk of cutaneous malignant melanoma and pattern of sun exposure in New Zealand. Int J Cancer 2000, 85:627-632.
31. Parisi A.V., Kimlin M.G., Lester R., et al. Lower body anatomical distribution of solar ultraviolet radiation on the human form in standing and sitting postures. J Photochem Photobiol B Biol 2003, 69:1-6.
32. Walter S.D., King W.D., Marrett L.D. Association of cutaneous malignant melanoma with intermittent exposure to ultraviolet radiation: results of a case-control study in Ontario, Canada. Int J Epidemiol 1999, 28:418-427.
33. Holman C.D., Armstrong B.K. Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types. J Natl Cancer Inst 1984, 73:75-82.
34. Pfahlberg A., Kolmel K.F., Gefeller O. Timing of excessive ultraviolet radiation and melanoma: epidemiology does not support the existence of a critical period of high susceptibility to solar ultraviolet radiation-induced melanoma. Br J Dermatol 2001, 144:471-475.
35. Dummer R. UV protection and skin cancer. Recent Results Cancer Res 2002, 160:7-12.
36. Moyal D., Fourtanier A.M. Broad-spectrum sunscreens provide better protection from the solar UV simulated radiation and natural sunlight-induced immunosuppression in humans. J Am Acad Dermatol 2008, 58(suppl 2):S149-S154.
37. Seite S., Fourtanier A.M. The benefits of daily photoprotection. J Am Acad Dermatol 2008, 58(suppl 2):S160-S166.
38. Levine J.A., Sorace M., Spencer J., et al. The indoor UV tanning industry: a review of skin cancer risk, health benefit claims, and regulation. J Am Acad Dermatol 2005, 53:1038-1044.
39. Swerdlow A.J., Weinstock M.A. Do tanning lamps cause melanoma?. An epidemiologic assessment. J Am Acad Derm 1998, 38:89-98.
40. Westerdahl J., Ingvar C., Masback A., et al. Risk of cutaneous melanoma in relation to use of sunbeds: further evidence for UV-A carcinogenicity. Br J Cancer 2000, 82:1593-1599.
41. Ting W., Schultz K., Cac N.N., et al. Tanning bed exposure increases the risk of malignant melanoma. Int J Dermatol 2007, 46:1253-1257.
42. Working groupon artificial ultraviolet (UV) light and skin cancer. Int J Cancer 2007, 120:1116-1122. International Agency for Research on Cancer.
43. On artificial ultraviolet (UV) light and skin cancer. The association of use of sunbeds with cutaneous malignant melanoma and other skin cancers: A systematic review. Int J Cancer 2007, 120:1116-1122. International Agency for Research on Cancer, Working Group.
44. Diffey B.L. A quantitative estimate of melanoma mortality from ultraviolet A sunbed use inthe U.K. Br J Dermatol 2003, 149:578-581.
45. Gandini S., Sera F., Cattaruzza M., et al. Meta-analysis of risk factors for cutaneous melanoma. III. Family history, actinic damage and phenotypic factors. Eur J Cancer 2005, 41:2040-2059.
46. Florell S.R., Boucher K.M., Garibotti G., et al. Population-based analysis of prognostic factors and survival in familial melanoma. J Clin Oncol 2005, 23:7168-7177.
47. Meyer K., Guldberg P. Genetic risk factors for melanoma. Hum Genet 2009, 120:499-510.
48. Begg C.B., Orlow I., Hummer A.J., et al. Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. J Natl Cancer Inst 2005, 97:1507-1515.
49. Bataille V., Bishop J.A., Sasieni P., et al. Risk of cutaneous melanoma in relation to the numbers, types and sites of naevi: a case-control study. Br J Cancer 1996, 73:1605-1611.
50. Tucker M.A. Melanoma epidemiology. Hematol/Oncol Clin North Am 2009, 23:383-395. vii.
51. Gandini S., Sera F., Cattaruzza M.S., et al. Meta-analysis of risk factors for cutaneous melanoma. I. Common and atypical naevi. Eur J Cancer 2005, 41:28-44.
52. Marks R. Epidemiology of melanoma. Clin Exp Dermatol 2000, 25:459-463.
53. Green A., Williams G., Neale R., et al. Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet 1999, 354:723-729.
54. Naylor M.F., Boyd A., Smith D.W., et al. High sun protection factor sunscreens in the suppression of actinic neoplasia. Arch Dermatol 1995, 131:170-175.
55. Snels D.G., Hille E.T., Gruis N.A., et al. Risk of cutaneous malignant melanoma in patients with nonfamilial atypical nevi from a pigmented lesions clinic. J Am Acad Dermatol 1999, 40:686-693.
56. MacLennan R., Kelly J.W., Rivers J.K., et al. The Eastern Australian Childhood Nevus Study: site differences in density and size of melanocytic nevi in relation to latitude and phenotype. J Am Acad Dermatol 2003, 48:367-375.
57. Lin J.Y., Fisher D.E. Melanocyte biology and skin pigmentation. Nature 2007, 445:843-850.
58. MacKie R.M., Hole D.J. Incidence and thickness of primary tumours and survival of patients with cutaneous malignant melanoma in relation to socioeconomic status. BMJ 1996, 312:1125-1128.
59. Eide M.J., Weinstock M.A., Clark M.A. Demographic and socioeconomic predictors of melanoma prognosis in the United States. J Health Care Poor Underserved 2009, 20:227-245.
60. Bates M.N. Registry-based case-control study of cancer in California firefighters. Am J Ind Med 2007, 50:339-344.
61. Vågerö D., Swerdlow A.J., Beral V. Occupation and malignant melanoma: a study based on cancer registration data in England and Wales and in Sweden. Br J Ind Med 1990, 47:317-324.
62. Moloney F.J., Comber H., O'Lorcain P., et al. Population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006, 154:498-504.
63. Renehan A.G., Tyson M., Egger M., et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet 2008, 371:569-578.